BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 15692473)

  • 1. Treatment of patch and plaque stage mycosis fungoides with imiquimod 5% cream.
    Deeths MJ; Chapman JT; Dellavalle RP; Zeng C; Aeling JL
    J Am Acad Dermatol; 2005 Feb; 52(2):275-80. PubMed ID: 15692473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete resolution of mycosis fungoides tumors with imiquimod 5% cream: a case series.
    Lewis DJ; Byekova YA; Emge DA; Duvic M
    J Dermatolog Treat; 2017 Sep; 28(6):567-569. PubMed ID: 28635518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of mycosis fungoides with imiquimod 5% cream.
    Ariffin N; Khorshid M
    Clin Exp Dermatol; 2006 Nov; 31(6):822-3. PubMed ID: 17040269
    [No Abstract]   [Full Text] [Related]  

  • 4. Solitary plaque mycosis fungoides on the penis responding to topical imiquimod therapy.
    Chiam LY; Chan YC
    Br J Dermatol; 2007 Mar; 156(3):560-2. PubMed ID: 17300249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imiquimod 5% cream in the treatment of mycosis fungoides--a pilot study.
    Chong A; Loo WJ; Banney L; Grant JW; Norris PG
    J Dermatolog Treat; 2004 Apr; 15(2):118-9. PubMed ID: 15204164
    [No Abstract]   [Full Text] [Related]  

  • 6. Topical imiquimod in the treatment of infantile hemangiomas: a retrospective study.
    Ho NT; Lansang P; Pope E
    J Am Acad Dermatol; 2007 Jan; 56(1):63-8. PubMed ID: 17190622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pilot study using topical imiquimod 5% cream in the treatment of nodular basal cell carcinoma after initial treatment with curettage.
    Neville JA; Williford PM; Jorizzo JL
    J Drugs Dermatol; 2007 Sep; 6(9):910-4. PubMed ID: 17941362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imiquimod in mycosis fungoides.
    Martínez-González MC; Verea-Hernando MM; Yebra-Pimentel MT; Del Pozo J; Mazaira M; Fonseca E
    Eur J Dermatol; 2008; 18(2):148-52. PubMed ID: 18424373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imiquimod induces complete clearance of a PUVA-resistant plaque in mycosis fungoides.
    Dummer R; Urosevic M; Kempf W; Kazakov D; Burg G
    Dermatology; 2003; 207(1):116-8. PubMed ID: 12835571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety, efficacy & recurrence rates of imiquimod cream 5% for treatment of anogenital warts.
    Diamantis ML; Bartlett BL; Tyring SK
    Skin Therapy Lett; 2009 Jun; 14(5):1-3, 5. PubMed ID: 19609471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Imiquimod in treatment of palpebral mycosis fungoides].
    Soler-Machín J; Gilaberte-Calzada Y; Vera-Alvarez J; Coscojuela-Santaliestra C; Martínez-Morales J; Osán-Tello M
    Arch Soc Esp Oftalmol; 2006 Apr; 81(4):221-3. PubMed ID: 16688647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tazarotene 0.1% gel for refractory mycosis fungoides lesions: an open-label pilot study.
    Apisarnthanarax N; Talpur R; Ward S; Ni X; Kim HW; Duvic M
    J Am Acad Dermatol; 2004 Apr; 50(4):600-7. PubMed ID: 15034511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical imiquimod as treatment for different kinds of cutaneous lymphoma.
    Coors EA; Schuler G; Von Den Driesch P
    Eur J Dermatol; 2006; 16(4):391-3. PubMed ID: 16935796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psoriasis induced by topical imiquimod.
    Wu JK; Siller G; Strutton G
    Australas J Dermatol; 2004 Feb; 45(1):47-50. PubMed ID: 14961909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies.
    Geisse J; Caro I; Lindholm J; Golitz L; Stampone P; Owens M
    J Am Acad Dermatol; 2004 May; 50(5):722-33. PubMed ID: 15097956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imiquimod 5% cream is an acceptable treatment option for external anogenital warts in uncircumcised males.
    Maw RD; Kinghorn GR; Bowman CA; Goh BT; Nayagam AT; Nathan M
    J Eur Acad Dermatol Venereol; 2002 Jan; 16(1):58-62. PubMed ID: 11952292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe.
    Schulze HJ; Cribier B; Requena L; Reifenberger J; Ferrándiz C; Garcia Diez A; Tebbs V; McRae S
    Br J Dermatol; 2005 May; 152(5):939-47. PubMed ID: 15888150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy with imiquimod 5% cream for eyelid nodular basal cell carcinoma.
    Blasi MA; Giammaria D; Balestrazzi E
    Am J Ophthalmol; 2005 Dec; 140(6):1136-9. PubMed ID: 16376667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Solar keratosis: from precancerous lesion to pre-invasive squamous cell carcinoma--therapeutic approach with a bioinductive method].
    Oster-Schmidt C; Altmeyer P; Markus S
    J Dtsch Dermatol Ges; 2003 Oct; 1(10):790-6. PubMed ID: 16281815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An open case series of patients with basal cell carcinoma treated with topical 5% imiquimod cream.
    Cowen E; Mercurio MG; Gaspari AA
    J Am Acad Dermatol; 2002 Oct; 47(4 Suppl):S240-8. PubMed ID: 12271286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.